AstraZeneca AG
- A10 - Antidiabéticos
- BYDUREON BCISE suspension for injection 2 mg
- FORXIGA film-coated tablet 10 mg
- FORXIGA film-coated tablet 5 mg
- KOMBIGLYZE XR prolonged-release tablet 1 000 mg+2.5 mg
- KOMBIGLYZE XR prolonged-release tablet 1 000 mg+5 mg
- KOMBIGLYZE XR prolonged-release tablet 500 mg+5 mg
- ONGLYZA film-coated tablet 2.5 mg
- ONGLYZA film-coated tablet 5 mg
- QTERN film-coated tablet 5 mg+10 mg
- XIGDUO XR film-coated tablet 1 000 mg+10 mg
- XIGDUO XR film-coated tablet 1 000 mg+5 mg
- XIGDUO XR film-coated tablet 500 mg+10 mg
- XIGDUO XR film-coated tablet 500 mg+5 mg
- B01 - Agentes antitrombóticos
- BRILIQUE film-coated tablet 60 mg
- BRILIQUE film-coated tablet 90 mg
- BRILIQUE orodispersible tablet 90 mg
- C07 - Betabloqueantes
- INDERAL tablet 10 mg
- INDERAL tablet 40 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- PEMZEK PLUS tablet 16 mg+12.5 mg
- PEMZEK PLUS tablet 32 mg+12.5 mg
- PEMZEK PLUS tablet 32 mg+25 mg
- PEMZEK PLUS tablet 8 mg+12.5 mg
- PEMZEK tablet 16 mg
- PEMZEK tablet 32 mg
- PEMZEK tablet 4 mg
- PEMZEK tablet 8 mg
- ZESTRIL tablet 30 mg
- J06 - Sueros inmunes e inmunoglobulinas
- SYNAGIS powder and solvent for solution for injection 100 mg/ml
- SYNAGIS powder and solvent for solution for injection 50 mg/0.5 ml
- L01 - Antineoplásicos
- CALQUENCE capsule, hard 100 mg
- CALQUENCE film-coated tablet 100 mg
- IMFINZI concentrate for solution for infusion 120 mg/2.4 ml
- IMFINZI concentrate for solution for infusion 500 mg/10 ml
- IMJUDO solution for infusion 25 mg/1.25 ml
- IMJUDO solution for infusion 300 mg/15 ml
- LYNPARZA film-coated tablet 100 mg
- LYNPARZA film-coated tablet 150 mg
- TAGRISSO film-coated tablet 40 mg
- TAGRISSO film-coated tablet 80 mg
- TRUQAP film-coated tablet 160 mg
- TRUQAP film-coated tablet 200 mg
- L02 - Terapia endocrina
- FASLODEX solution for injection 250 mg/5 ml
- NOLVADEX film-coated tablet 20 mg
- ZOLADEX LA SAFESYSTEM implant 10.8 mg
- ZOLADEX SAFESYSTEM implant 3.6 mg
- L04 - Inmunosupresores
- SAPHNELO concentrate for solution for infusion 300 mg/2 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- WAINZUA PRE-FILLED PEN solution for injection 45 mg/0.8 ml
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- BRICANYL TURBUHALER inhalation powder 0.5 mg/dose
- DAXAS film-coated tablet 500 µg
- FASENRA PEN solution for injection 30 mg/ml
- FASENRA PREFILLED SYRINGE solution for injection 30 mg/ml
- OXIS TURBUHALER inhalation powder 12 µg/dose
- OXIS TURBUHALER inhalation powder 6 µg/dose
- PULMICORT RESPULES nebuliser suspension 0.125 mg/ml
- PULMICORT RESPULES nebuliser suspension 0.25 mg/ml
- PULMICORT RESPULES nebuliser suspension 0.5 mg/ml
- PULMICORT TURBUHALER inhalation powder 100 µg/dose
- PULMICORT TURBUHALER inhalation powder 200 µg/dose
- PULMICORT TURBUHALER inhalation powder 400 µg/dose
- SYMBICORT TURBUHALER inhalation powder 12 µg/dose+400 µg/dose
- SYMBICORT TURBUHALER inhalation powder 6 µg/dose+100 µg/dose
- SYMBICORT TURBUHALER inhalation powder 6 µg/dose+200 µg/dose
- TEZSPIRE PREFILLED PEN solution for injection 210 mg/1.91 ml
- TEZSPIRE PREFILLED SYRINGE solution for injection 210 mg/1.91 ml
- TRIXEO AEROSPHERE pressurised inhalation, suspension 5 µg/dosis+7.2 µg/dosis+160 µg/dosis
- VANNAIR pressurised inhalation, suspension 6 µg/dose+100 µg/dose
- VANNAIR pressurised inhalation, suspension 6 µg/dose+200 µg/dose
- V03 - Todos los demás preparados terapéuticos
- ONDEXXYA powder for solution for injection 200 mg